Stay updated on Durva + Domva After ChemoRad in Stage III NSCLC Clinical Trial
Sign up to get notified when there's something new on the Durva + Domva After ChemoRad in Stage III NSCLC Clinical Trial page.

Latest updates to the Durva + Domva After ChemoRad in Stage III NSCLC Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check23 days agoNo Change Detected
- Check31 days agoChange DetectedThe study has increased its number of locations from 246 to 247, and the research site in Veracruz, Mexico has been marked as withdrawn. Additionally, the status of the study has changed from 'not yet recruiting' to 'withdrawn'.SummaryDifference2%
- Check45 days agoChange DetectedThe web page has been updated to reflect a new version (v2.14.2) of the NLM-NCBI services and products, along with a notice regarding heavy traffic that may impact performance and availability.SummaryDifference0.9%
- Check54 days agoChange DetectedThe website has been updated to version v2.14.1, with the previous version v2.14.0 now removed, and a new status of 'Suspended' has been added.SummaryDifference1%
- Check75 days agoChange DetectedThe website has updated the 'type of intervention' feature from version v2.13.3 to v2.14.0, indicating a significant change in this functionality.SummaryDifference0.2%
- Check83 days agoChange DetectedThe study has expanded from 240 to 246 locations, with new research sites added in Wisconsin, Brazil, Germany, and India, while the last update was posted on December 20, 2024.SummaryDifference2%
- Check97 days agoChange DetectedThe website has been updated from version v2.13.2 to v2.13.3.SummaryDifference0.1%
Stay in the know with updates to Durva + Domva After ChemoRad in Stage III NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Durva + Domva After ChemoRad in Stage III NSCLC Clinical Trial page.